37 Spam-Free Article(s) Found
| Symbol |
Name |
Last Close |
Mkt Cap |
DailyStocks'
Rating
|
| JAZZ |
Jazz Pharmaceuticals plc |
$161.01 |
$9.73B |
N/A | |
http://www.latimes.com/sports/nba/la-sp-james-harden-rockets-jazz-nba-playoffs-20190424-story.html
Apr 24, 2019 - James Harden scored 26 points and the Houston Rockets outlasted the Utah Jazz 100-93 on Wednesday night to win their first-round playoff series 4-1.
The Rockets advanced to the Western Conference semifinals for the third straight season and will face the winner of the Los Angeles Clippers-Golden...
0
lt:4664673085746202586
0
http://www.zacks.com/stock/news/405859/jazz-pharmaceuticals-jazz-reports-next-week-wall-street-expects-earnings-growth?cid=CS-ZC-FT-405859
Apr 30, 2019 - Jazz (JAZZ) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
zc:4594133436556385581
0
http://www.latimes.com/entertainment/movies/la-et-mn-mini-buddy-bolden-movie-jazz-review-20190502-story.html
May 02, 2019 - No one could ever call “Bolden,” a vivid and inventive musical-drama about the unsung life of New Orleans jazz “inventor” Charles “Buddy” Bolden, a by-the-numbers biopic.
Director Dan Pritzker, who wrote the kaleidoscopic, dialogue-light script with David N. Rothschild, has crafted a largely conjectured,...
0
lt:-6277590645437591109
0
https://seekingalpha.com/article/4261119-jazz-pharmaceuticals-plc-2019-q1-results-earnings-call-slides?source=feed_sector_healthcare
May 07, 2019 - The following slide deck was published by Jazz Pharmaceuticals plc in conjunction with their 2019 Q1 earnings call.
0
sa:5426050915331323142
0
http://www.nydailynews.com/new-york/ny-verna-hart-art-jazz-obituary-20190508-jeov2mkdhfd5fdjo5bn723fn5e-story.html
May 07, 2019 - Verna Hart — the Harlem-born artist who developed her childhood passions into a successful career by blending painting and music to praise jazz and its performers — will be remembered Thursdayat funeral services in Queens.
Hart died in her sleep April 26 in Wilmington, Del., according to her family....
0
nydn:7492309327095915898
0
https://www.fool.com/earnings/call-transcripts/2019/05/08/jazz-pharmaceuticals-jazz-q1-2019-earnings-call-tr.aspx?source=iedfolrf0000001
May 08, 2019 - JAZZ earnings call for the period ending March 31, 2019.
0
fool:8789530332057148790
0
https://www.fool.com/investing/2019/05/08/jazz-pharmaceuticals-hits-all-the-right-notes-in-q.aspx?source=iedfolrf0000001
May 08, 2019 - The drugmaker reported strong revenue and earnings growth thanks largely to solid growth for narcolepsy drug Xyrem.
0
fool:-664081704752478407
0
http://www.zacks.com/stock/news/410916/jazz-pharma-jazz-q1-earnings-and-sales-beat-estimates?cid=CS-ZC-FT-410916
May 08, 2019 - Jazz Pharmaceuticals (JAZZ) reports encouraging first-quarter 2019 earnings and revenues and maintains its guidance for 2019.
zc:-8562411932341268484
0
http://www.zacks.com/stock/news/412509/3-reasons-why-growth-investors-shouldnt-overlook-jazz-jazz?cid=CS-ZC-FT-412509
May 10, 2019 - Jazz (JAZZ) is well positioned to outperform the market, as it exhibits above-average growth in financials.
zc:-7816259811666888159
0
http://www.zacks.com/stock/news/416789/jazz-vs-pcrx-which-stock-should-value-investors-buy-now?cid=CS-ZC-FT-416789
May 20, 2019 - JAZZ vs. PCRX: Which Stock Is the Better Value Option?
zc:-2222044352086970908
0
